Enterprise Value Chart

Historical Enterprise Value Data

View and export this data back to 2015. Start Trial.
Date Value
October 21, 2026 403.67M
October 20, 2026 408.87M
October 19, 2026 404.04M
October 16, 2026 415.18M
October 15, 2026 404.78M
October 14, 2026 393.27M
October 13, 2026 405.15M
October 12, 2026 424.84M
October 09, 2026 424.84M
October 08, 2026 433.38M
October 07, 2026 431.53M
October 06, 2026 433.01M
October 05, 2026 425.95M
October 02, 2026 420.75M
October 01, 2026 412.95M
September 30, 2026 426.33M
September 29, 2026 423.35M
September 28, 2026 430.41M
September 25, 2026 428.93M
September 24, 2026 424.47M
September 23, 2026 425.21M
September 22, 2026 446.01M
September 21, 2026 448.24M
September 18, 2026 445.27M
September 17, 2026 442.30M
Date Value
September 16, 2026 441.18M
September 15, 2026 453.44M
September 14, 2026 496.16M
September 11, 2026 489.84M
September 10, 2026 484.27M
September 09, 2026 490.96M
September 08, 2026 506.19M
September 04, 2026 506.93M
September 03, 2026 495.05M
September 02, 2026 495.42M
September 01, 2026 486.13M
August 31, 2026 494.67M
August 28, 2026 489.47M
August 27, 2026 491.70M
August 26, 2026 492.45M
August 25, 2026 496.53M
August 24, 2026 482.04M
August 21, 2026 479.44M
August 20, 2026 454.18M
August 19, 2026 478.33M
August 18, 2026 459.39M
August 17, 2026 456.41M
August 14, 2026 459.39M
August 13, 2026 469.04M
August 12, 2026 450.10M

Enterprise Value Definition

EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.

Read full definition.

Enterprise Value Range, Past 5 Years

View Enterprise Value Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Enterprise Value Benchmarks

View Enterprise Value Benchmarks
Start Trial
Agenus, Inc. 537.40M
Amgen, Inc. 280.28B
Anika Therapeutics, Inc. 262.53M
BioCryst Pharmaceuticals, Inc. 2.462B
Imunon, Inc. 6.533M